Key Insights
The US diabetes devices market, valued at $25.16 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of diabetes, an aging population, and increasing adoption of advanced technologies like continuous glucose monitoring (CGM) systems and insulin pumps. The market's 6.27% CAGR from 2025-2033 indicates significant expansion opportunities across various segments. Growth is fueled by a shift towards minimally invasive and convenient treatment options, personalized diabetes management, and improved data-driven insights provided by sophisticated monitoring devices. Key segments include lancets, management devices (insulin pumps, infusion sets, pens, jet injectors), and monitoring devices (self-monitoring blood glucose meters and CGM systems). Leading players such as Abbott, Medtronic, Dexcom, and Novo Nordisk are leveraging technological advancements and strategic collaborations to consolidate their market positions. However, high costs associated with advanced devices and potential reimbursement challenges may act as restraints. The regional breakdown, focusing on the United States, reveals varying market dynamics across Northeast, Southeast, Midwest, Southwest, and West, influenced by demographic factors and healthcare infrastructure variations. Growth in the coming years will likely be shaped by increasing telehealth adoption, innovative device designs that improve patient adherence, and the development of integrated solutions that streamline diabetes management.
The competitive landscape is characterized by a blend of established players and emerging companies, each vying for market share through product innovation, strategic partnerships, and expansion into new regions. The historical period (2019-2024) provides a foundation for forecasting future market performance. Continued investment in research and development, focusing on closed-loop systems and artificial intelligence-driven solutions, is anticipated to significantly propel market growth throughout the forecast period (2025-2033). While precise market segmentation data was not provided, market analysis suggests that CGM devices and insulin pumps will be significant growth drivers due to their improved accuracy and ease of use compared to traditional methods. The focus on improving patient outcomes and reducing the burden of diabetes management is expected to underpin the expansion of this market sector within the United States.
US Diabetes Devices Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the US Diabetes Devices Market, offering crucial insights for industry stakeholders, investors, and strategic decision-makers. The study period covers 2019-2033, with a base year of 2025 and a forecast period of 2025-2033. The report leverages historical data (2019-2024) to project future market trends and growth opportunities within the dynamic landscape of diabetes management. This report is delivered without modification; no further alterations are required.
US Diabetes Devices Market Market Concentration & Dynamics
The US diabetes devices market exhibits a moderately concentrated structure, with key players such as Medtronic, Abbott, Dexcom, and Novo Nordisk holding significant market share. However, the presence of numerous smaller companies and continuous innovation fosters a competitive environment. Market concentration is further analyzed through detailed company share analysis, revealing the competitive landscape and market dynamics. The market is shaped by a robust innovation ecosystem, driven by ongoing research and development in continuous glucose monitoring (CGM) and insulin delivery systems. Stringent regulatory frameworks, primarily governed by the FDA, significantly influence product approvals and market entry. The presence of substitute products, including lifestyle modifications and alternative therapies, presents competitive challenges. End-user trends, marked by a growing preference for technologically advanced and user-friendly devices, are influencing market growth. Furthermore, the report details mergers and acquisitions (M&A) activities, with a focus on deal counts and their impact on market consolidation during the historical period.
- Key Metrics: Market Share of Top Players (xx%), Number of M&A deals (xx).
- Innovation Ecosystem: Focus on CGM and Insulin delivery systems.
- Regulatory Framework: FDA regulations and their influence.
- Substitute Products: Impact of alternative therapies.
- End-User Trends: Preference for advanced, user-friendly devices.
US Diabetes Devices Market Industry Insights & Trends
The US diabetes devices market is experiencing robust growth, driven by the rising prevalence of diabetes and increased adoption of advanced technologies. Market size in 2025 is estimated at $xx Million, exhibiting a compound annual growth rate (CAGR) of xx% during the forecast period (2025-2033). Technological disruptions, particularly in CGM and insulin pump technologies, are revolutionizing diabetes management, leading to improved accuracy, convenience, and patient outcomes. Evolving consumer behaviors, with an increasing demand for personalized and integrated solutions, are further propelling market expansion. The market is also affected by increasing healthcare expenditure and technological advancements in diabetes monitoring and management. This report provides an in-depth analysis of these trends. The report examines growth drivers, technological disruptions, and evolving consumer behaviours, providing insights into the market's dynamic evolution.
Key Markets & Segments Leading US Diabetes Devices Market
The US market dominates the North American diabetes devices market. Within the US market, several segments exhibit strong growth potential.
- Lancets: Market growth is fueled by the increasing adoption of self-monitoring blood glucose (SMBG) devices.
- Continuous Glucose Monitoring (CGM): Rapid technological advancements and improved accuracy are driving substantial market growth. Dexcom and Abbott are key players here.
- Management Devices (Insulin Pumps): Demand for insulin pumps is increasing due to the rising prevalence of Type 1 diabetes and increased preference for automated insulin delivery systems. Omnipod, Medtronic, and Insulet Corporation are key players.
- Infusion Sets: This segment is directly linked to the growth of insulin pump usage.
- Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors: These are more traditional methods but still hold considerable market share, particularly amongst individuals preferring less technologically advanced methods.
- Monitoring Devices (Self-monitoring Blood Glucose): This segment remains significant due to its affordability and accessibility, although CGM is progressively gaining market share. LifeScan and Abbott are key players.
Drivers: Increased prevalence of diabetes, rising healthcare expenditure, technological advancements, aging population, improved reimbursement policies.
US Diabetes Devices Market Product Developments
Recent years have witnessed significant product innovations in the US diabetes devices market, characterized by the development of advanced CGM systems with improved accuracy and ease of use, as well as the introduction of closed-loop insulin delivery systems offering greater automation and precision. These advancements significantly enhance patient outcomes and improve the overall management of diabetes. The focus is on miniaturization, improved accuracy, and enhanced user experience, creating a competitive edge in the market.
Challenges in the US Diabetes Devices Market Market
The US diabetes devices market faces several challenges including high device costs, reimbursement complexities, stringent regulatory requirements causing delays in product launches, and supply chain disruptions impacting device availability. These factors can constrain market growth and necessitate innovative solutions to navigate these obstacles. The competitive landscape further adds complexity, with established players and new entrants constantly vying for market share.
Forces Driving US Diabetes Devices Market Growth
Several factors fuel the growth of the US diabetes devices market, including:
- Technological Advancements: Miniaturization, enhanced accuracy, and integration of smart technologies within devices.
- Economic Growth: Increased healthcare spending in the US boosts the market.
- Regulatory Support: FDA approvals for innovative devices drive market entry. For example, the FDA clearance for Roche's Accu-Chek Solo micropump system.
Long-Term Growth Catalysts in the US Diabetes Devices Market
Long-term growth catalysts include the development of advanced artificial pancreas systems, improved data analytics capabilities to personalize diabetes management, expansion into underserved markets, and strategic partnerships among device manufacturers, healthcare providers, and technology companies. These factors will likely lead to a sustained increase in market size and expansion.
Emerging Opportunities in US Diabetes Devices Market
Emerging opportunities lie in the development of integrated diabetes management platforms, the use of artificial intelligence and machine learning to improve disease prediction and personalized treatment, and the expansion into new market segments including children and underserved populations. The demand for remote monitoring and telehealth solutions also presents substantial opportunities.
Leading Players in the US Diabetes Devices Market Sector
- Omnipod
- Insulin Devices
- LifeScan
- Dexcom (Dexcom)
- Becton and Dickenson
- Abbott (Abbott)
- F Hoffmann-La Roche AG (F Hoffmann-La Roche AG)
- Novo Nordisk (Novo Nordisk)
- Medtronic (Medtronic)
- Other Self-monitoring Blood Glucose Devices
- Sanofi (Sanofi)
- Johnson & Johnson (Johnson & Johnson)
- Ypsomed Holding (Ypsomed Holding)
- Tandem
- Other Insulin Device
- Insulet Corporation (Insulet Corporation)
- Eli Lilly and Company (Eli Lilly and Company)
Key Milestones in US Diabetes Devices Market Industry
- August 2023: The FDA granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump. This represents a significant advancement in insulin delivery technology.
- March 2022: Dexcom released the G7 CGM system in the U.K., with plans for a US release pending FDA approval. This launch signifies a step towards broader CGM adoption.
Strategic Outlook for US Diabetes Devices Market Market
The US diabetes devices market is poised for substantial growth, driven by technological advancements, increased prevalence of diabetes, and favorable regulatory environments. Strategic opportunities abound for companies focused on innovation, partnerships, and expansion into underserved markets. The focus on personalized medicine and integration of data-driven approaches will further fuel market expansion.
US Diabetes Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
US Diabetes Devices Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
US Diabetes Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.27% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Growing Diabetes and Obesity Population in the United States
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Northeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 12. Southeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 13. Midwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. Southwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. West US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 1 Omnipod
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Insulin Devices
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 4 Other Continuous Glucose Monitoring Devices
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 3 LifeScan
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 1 Dexcom
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Becton and Dickenson
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 3 Abbott
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 F Hoffmann-La Roche AG
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 2 Novo Nordisk
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 2 Medtronic
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 4 Other Self-monitoring Blood Glucose Devices
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Abbott
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Self-monitoring Blood Glucose Devices
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.14 Novo Nordisk
- 16.2.14.1. Overview
- 16.2.14.2. Products
- 16.2.14.3. SWOT Analysis
- 16.2.14.4. Recent Developments
- 16.2.14.5. Financials (Based on Availability)
- 16.2.15 Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 16.2.15.1. Overview
- 16.2.15.2. Products
- 16.2.15.3. SWOT Analysis
- 16.2.15.4. Recent Developments
- 16.2.15.5. Financials (Based on Availability)
- 16.2.16 Sanofi
- 16.2.16.1. Overview
- 16.2.16.2. Products
- 16.2.16.3. SWOT Analysis
- 16.2.16.4. Recent Developments
- 16.2.16.5. Financials (Based on Availability)
- 16.2.17 Johnson & Johnson
- 16.2.17.1. Overview
- 16.2.17.2. Products
- 16.2.17.3. SWOT Analysis
- 16.2.17.4. Recent Developments
- 16.2.17.5. Financials (Based on Availability)
- 16.2.18 Ypsomed Holding
- 16.2.18.1. Overview
- 16.2.18.2. Products
- 16.2.18.3. SWOT Analysis
- 16.2.18.4. Recent Developments
- 16.2.18.5. Financials (Based on Availability)
- 16.2.19 Medtronic
- 16.2.19.1. Overview
- 16.2.19.2. Products
- 16.2.19.3. SWOT Analysis
- 16.2.19.4. Recent Developments
- 16.2.19.5. Financials (Based on Availability)
- 16.2.20 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 16.2.20.1. Overview
- 16.2.20.2. Products
- 16.2.20.3. SWOT Analysis
- 16.2.20.4. Recent Developments
- 16.2.20.5. Financials (Based on Availability)
- 16.2.21 2 F Hoffmann-La Roche AG
- 16.2.21.1. Overview
- 16.2.21.2. Products
- 16.2.21.3. SWOT Analysis
- 16.2.21.4. Recent Developments
- 16.2.21.5. Financials (Based on Availability)
- 16.2.22 3 Johnson & Johnson
- 16.2.22.1. Overview
- 16.2.22.2. Products
- 16.2.22.3. SWOT Analysis
- 16.2.22.4. Recent Developments
- 16.2.22.5. Financials (Based on Availability)
- 16.2.23 Dexcom
- 16.2.23.1. Overview
- 16.2.23.2. Products
- 16.2.23.3. SWOT Analysis
- 16.2.23.4. Recent Developments
- 16.2.23.5. Financials (Based on Availability)
- 16.2.24 1 Abbott
- 16.2.24.1. Overview
- 16.2.24.2. Products
- 16.2.24.3. SWOT Analysis
- 16.2.24.4. Recent Developments
- 16.2.24.5. Financials (Based on Availability)
- 16.2.25 Continuous Glucose Monitoring Devices
- 16.2.25.1. Overview
- 16.2.25.2. Products
- 16.2.25.3. SWOT Analysis
- 16.2.25.4. Recent Developments
- 16.2.25.5. Financials (Based on Availability)
- 16.2.26 Tandem
- 16.2.26.1. Overview
- 16.2.26.2. Products
- 16.2.26.3. SWOT Analysis
- 16.2.26.4. Recent Developments
- 16.2.26.5. Financials (Based on Availability)
- 16.2.27 4 Other Insulin Device
- 16.2.27.1. Overview
- 16.2.27.2. Products
- 16.2.27.3. SWOT Analysis
- 16.2.27.4. Recent Developments
- 16.2.27.5. Financials (Based on Availability)
- 16.2.28 Insulet Corporation
- 16.2.28.1. Overview
- 16.2.28.2. Products
- 16.2.28.3. SWOT Analysis
- 16.2.28.4. Recent Developments
- 16.2.28.5. Financials (Based on Availability)
- 16.2.1 1 Omnipod
List of Figures
- Figure 1: Global US Diabetes Devices Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: United states US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 3: United states US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 9: North America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 15: South America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Northeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Southeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Midwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Southwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: West US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 12: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 13: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: United States US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Canada US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 18: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 19: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 20: Brazil US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Argentina US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Rest of South America US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 24: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 25: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 26: United Kingdom US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Germany US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: France US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Italy US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Spain US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Russia US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Benelux US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 33: Nordics US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Rest of Europe US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 36: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 37: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 38: Turkey US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Israel US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: GCC US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 41: North Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: South Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: Rest of Middle East & Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 45: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 46: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 47: China US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: India US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Japan US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: South Korea US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 51: ASEAN US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Oceania US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 53: Rest of Asia Pacific US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the US Diabetes Devices Market?
The projected CAGR is approximately 6.27%.
2. Which companies are prominent players in the US Diabetes Devices Market?
Key companies in the market include 1 Omnipod, Insulin Devices, 4 Other Continuous Glucose Monitoring Devices, 3 LifeScan, 1 Dexcom, Becton and Dickenson, 3 Abbott, F Hoffmann-La Roche AG, 2 Novo Nordisk, 2 Medtronic, 4 Other Self-monitoring Blood Glucose Devices, Abbott, Self-monitoring Blood Glucose Devices, Novo Nordisk, Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Sanofi, Johnson & Johnson, Ypsomed Holding, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, 2 F Hoffmann-La Roche AG, 3 Johnson & Johnson, Dexcom, 1 Abbott, Continuous Glucose Monitoring Devices, Tandem, 4 Other Insulin Device, Insulet Corporation.
3. What are the main segments of the US Diabetes Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 25.16 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Growing Diabetes and Obesity Population in the United States.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "US Diabetes Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the US Diabetes Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the US Diabetes Devices Market?
To stay informed about further developments, trends, and reports in the US Diabetes Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
